Antibacterial drugs play a major role in the prevention of infectious diseases, though cases of drug misuse and overuse, led to the increased development of drug resistance. Different manufacturers are launching technologically advanced products to help scientists treat patients better. With the increasing numbers of infectious diseases, there is a higher demand of its early diagnosis to give better clinical access to healthcare professionals.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-antimicrobial-susceptibility-testing-market
Data Bridge Market Research analyses that the Global Antimicrobial Susceptibility Testing Market is growing with a CAGR of 5.9% from 2022 to 2029 and is expected to reach USD 5,688.50 million by 2029 from USD 3,616.78 million in 2021. The increasing demand for the antimicrobial susceptibility testing will provide potential opportunities for the market growth in the forecast period.
Increasing prevalence of infectious diseases is anticipated to drives the market's growth rate
With the increasing number of infectious diseases, there is a rise in demand for early diagnosis to give better clinical access to healthcare professionals. Since these diseases are infectious in nature, they can easily transfer from person to person, and therefore, the threat is high. Infectious diseases can get contaminated from one person to another, and these diseases have similar signs and symptoms. For instance, as per World Health Organization, in 2019, around 1.4 million people died from tuberculosis worldwide
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Instruments, Consumables & Accessories, and Services & Software), Methods (Mass Spectrometry Method, Dilution, Disk Diffusion, E-Test, Genotypic Methods & Others), Type (Antibacterial Testing, Antifungal Testing & Rapid-AST), Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology & Others), End User (Hospitals, Pharmaceuticals and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Research Centres and Academic Institutes & Others), Distribution Channel (Direct Sales, Retail Sales & Third Party Distributor)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
BD (U.S.), Mast Group Ltd (U.K.)., Thermo Fisher Scientific Inc.(U.S.), Bio-Rad Laboratories, Inc. (U.S.), and BGI (China), B.D. (U.S.), Danaher (U.S.), Creative Diagnostics (U.S.), Erba Group (U.S.), Alifax S.r.l. (Italy), Accelerate Diagnostics, Inc. (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
The global antimicrobial susceptibility testing market is categorized into six notable segments which are based on product type, methods, type, application, end user and distribution channel.
- On the basis of product type, global antimicrobial susceptibility testing market is segmented into instruments, consumables & accessories and software & services.
The instruments segment of product type segment is anticipated to dominate the antimicrobial susceptibility testing market
The instruments segment is expected to dominate the global antimicrobial susceptibility testing market with 58.0% market share due to high technology adoption and launch of numerous types of susceptibility testing instruments by major market players in the market.
- On the basis of methods, global antimicrobial susceptibility testing market is segmented into disk diffusion, dilution, mass spectrometry method, e-test, genotypic methods and others.
The disk diffusion segment of methods segment is anticipated to dominate the antimicrobial susceptibility testing market
The disk diffusion segment is expected to dominate the global antimicrobial susceptibility testing market with 42.7% market share due to its accurate, reliable, and efficient results.
- On the basis of type, global antimicrobial susceptibility testing market is segmented into anti bacterial, anti fungal testing and others. The anti bacterial testing segment is expected to dominate the market with 73.5% market share due to huge number of tests available in the market.
- On the basis of application, global antimicrobial susceptibility testing market is segmented into market is segmented into clinical diagnostics, drug discovery & development, epidemiology & others. The clinical diagnostics segment is expected to dominate the global antimicrobial susceptibility testing market with 71.3% market share because these tests are most commonly done to detect the microbes to help the microbiologist to get access to better clinical diagnosis.
- On the basis of end user, global antimicrobial susceptibility testing market is segmented into hospitals, diagnostic laboratories, pharmaceutical & biotechnology companies, contract research organizations, research centres & academic institutes and others. The hospitals segment is expected to dominate the global antimicrobial susceptibility testing market with 53.7% market share as these antimicrobial tests are performed in hospitals to a great extent.
- On the basis of distribution channel, global antimicrobial susceptibility testing market is segmented into direct sales, retail sales and third party distributor. The direct sales segment is expected to dominate the global antimicrobial susceptibility testing market with 71.7% market share as consumers are aware of this distribution channel and they prefer direct sales for seeking the benefits of discounts, bulk buying and easy availability of products
Major Players
Data Bridge Market Research recognizes the following companies as the major antimicrobial susceptibility testing market players in antimicrobial susceptibility testing market are BD (U.S.), Mast Group Ltd (U.K.)., Thermo Fisher Scientific Inc.(U.S.), Bio-Rad Laboratories, Inc. (U.S.), and BGI (China), B.D. (U.S.), Danaher (U.S.), Creative Diagnostics (U.S.), Erba Group (U.S.), Alifax S.r.l. (Italy), Accelerate Diagnostics, Inc. (U.S.).
Market Development
- In 2020, Cepheid, a subsidiary of Danaher, launched a novel rapid molecular test for TB that can detect multi-drug resistance to first-line and second-line drugs simultaneously. The result can be obtained in less than 90 minutes. This will enhance the antimicrobial testing market in the coming years.
- In 2020, Thermo Fisher Scientific Inc. added imipenem/sulbactam ARIS HiQ to its automated and manual antimicrobial susceptibility testing portfolio, which will act as treatment for urinary tract infections. It will also enhance options for antimicrobial testing in clinical settings. This will boost the growth of the market in upcoming years
Regional Analysis
Geographically, the countries covered in the antimicrobial susceptibility testing market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in antimicrobial susceptibility testing market during the forecast period 2022 to 2029
North America dominates the antimicrobial susceptibility testing market due to the increasing investments in development of novel methods for testing. Furthermore, U.S is witnessing huge growth in North America market due to increase in pandemic events and presence of advanced healthcare infrastructure.
Asia-Pacific is estimated to be the fastest-growing region in antimicrobial susceptibility testing market the forecast period 2022 to 2029
Asia-Pacific is expected to grow during the forecast period of 2022 to 2029 because of major market players existing into the market, such as Thermo Fisher Scientific Inc. and Bio-Rad Laboratories Inc. Also, the increasing investments in the development of novel methods for testing also boost the market growth.
For more detailed information about antimicrobial susceptibility testing market report, click here – https://www.databridgemarketresearch.com/reports/global-antimicrobial-susceptibility-testing-market
